5 models fit Mondelez International Inc. Class A Common Stock and they disagree: 0 of 5 land within 15% of the average.
Two or more of our models back this value.
Premium(i)Silver66
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionMondelez International Inc. Class A Common Stock (MDLZ)
Fair value (5 models)
$49.28
ACCE price target
$64.00
Rating
Overvalued
Horizon
12 months
Fair value published on 20 Oct 2026, 16:04 CEST; previously $54.64 since 16 Oct 2026, 00:00 CEST.
ACCE price target published on 19 Sept 2026, 00:00 CEST.
Rating published on 20 Oct 2026, 16:04 CEST.
Price used: $63.80 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
29.5% above
-22.8% to fair value
ACCE score
64
out of 100
Analysts
65% buy
23 covering
P/E
23.0x
forward 18.2x
1-year return
+4.6%
Dividend yield
3.19%
Mondelez International Inc. Class A Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Mondelez manufactures and distributes chocolate, biscuits, and gum across 150 countries, with Oreo, Cadbury, and Trident as its largest brands by revenue contribution. The company benefits from pricing power in developed markets and exposure to growing middle-class consumption in emerging economies, where snacking categories are still underpenetrated relative to developed peers. Revenue growth of 4.1% masks stronger underlying momentum in higher-margin categories like chocolate, which is being driven by premiumization and innovation in formats like single-serve and functional snacks. At a forward PE of 18.0 against a 22.0% operating margin, the valuation offers modest upside if the company can sustain mid-single-digit organic growth while continuing to expand margins through mix shift toward chocolate and emerging markets, where operating leverage remains available. The stock's absence from major indices creates a structural discount despite the scale and cash generation profile of the business.
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
moderate
Sequential revenue decline
QoQ revenue fell 7.2% despite 4.1% YoY growth, signalling recent deceleration or seasonal weakness that warrants monitoring.
moderate
Insider selling concentration
Last 10 disclosures show $8.56M in sales with zero buys. Absence of insider conviction during valuation near fair value is a mild negative signal.
moderate
Quality score lagging
ACCE Quality component at 56/100 is the weakest pillar. Combined with moderate valuation (V:58), suggests execution or operational risks beneath headline earnings growth.
AI research notes
AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Management has shrunk share count by 3.6% while growing revenue 4.1%, demonstrating disciplined capital allocation.
The company generates $2.3B in free cash flow and trades at a 2.9% yield, providing steady shareholder returns.
Analysts rate 65% of the stock Buy or Strong Buy with a mean target of $69.00, implying 14.2% upside.
Why it could disappoint
The stock trades at $60.41 versus a consensus fair value of $53.32, representing 11.7% overvaluation across five models.
Return on invested capital of 4.3% trails the 5.2% risk-free rate, meaning capital is not earning its cost.
Current price implies only 3.0% annual cash flow growth over five years, well below the 7.0% five-year average.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Oct 29, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where MDLZ's valuation models land
Price
$63.80
Model fair value
$49.28
Model range
$23.88 to $71.05
Fair value $49.28
Price $63.80
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores